The Paediatric Rheumatology INternational Trials Organisation (PRINTO) is a not for profit, non governmental, international research network founded by Alberto Martini and Nicolino Ruperto in 1996. The coordinating centre is based in Genoa. PRINTO initially included 14 European countries (about 88 countries, 643 centres worldwide with 1352 members today), with the goal to foster, facilitate and co-ordinate the development, conduct, analysis, and reporting of multi-centres, international clinical trials and/or outcome standardisation studies in children with paediatric rheumatic diseases (PRD).
Via Gaslini, 5
Genova
Liguria
16147
Italy

Paediatric Rheumatology INternational Trials Organisation (PRINTO)

The Paediatric Rheumatology INternational Trials Organisation (PRINTO) is a not for profit, non governmental, international research network founded by Alberto Martini and Nicolino Ruperto in 1996. PRINTO initially included 14 European countries (about 88 countries, 643 centres worldwide with 1352 members today), with the goal to foster, facilitate and co-ordinate the development, conduct, analysis, and reporting of multi-centres, international clinical trials and/or outcome standardisation studies in children with paediatric rheumatic diseases (PRD).

The coordinating centre is based in Genoa.
To learn more about PRINTO click here
To download the PRINTO brochure click here


IN THE SPOTLIGHT

  • 16-AUG-2018
    Consensus proposal for Taxonomy of the Autoinflammatory Diseases (AIDs): ma...
    Paper details...
  • 24-MAY-2018
    Subcutaneous Abatacept in poly JIA Manuscript published in Arthritis & Rheu...
    More details...
  • 03-MAY-2018
    Genoa will host the 2019 Meeting of the International Society of Systemic A...
    More details...
  • 23-APR-2018
    Results of an international delphi survey for the definition of the variabl...
    Paper details...
  • 12-APR-2018
    The PRINTO JAMAR Supplement published online in Rheumatology International
    Read more...
  • 03-APR-2018
    ERN RITA : Bursaries for Junior Doctors 2018-2019
    More details...
  • 01-OCT-2017
    Development & Initial Validation of the MAS Score manuscript published in T...
    Paper details...
  • 26-JAN-2017
    Changes in Gene Expression in sJIA Patients on Canakinumab manuscript publi...
    Paper details...

PROJECTS

  • conect4children (c4c)
    PRINTO is partner of the "conect4children" (c4c) initiative, the collaborative network for European clinical trials for children, (c4c) a consortium that aims to enhance the competitiveness of Europe as a critical region for developing medicines for children.
    Learn More
  • Liaisons with pharmaceutical companies
    PRINTO is working with pharmaceutical companies as advisor for trials planning, centre selection, data collection, data analysis and interpretation…
    Learn More
  • STARS
    The comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS trial (STARS) is a new interventional trial aiming to investigate whether an early aggressive therapeutic intervention in children with JIA, based on the initial start of synthetic and biologic DMARDs (Step-down strategy), is superior to an approach based on treatment escalation conducted following the treat-to-target principle (Step-up strategy).
    Learn More
  • JIA classification study
    The PRINTO Evidence-based Revision of the International League Against Rheumatism (ILAR) Classification criteria for juvenile idiopathic Arthritis.
    Learn More
  • Eurofever Project
    The PReS Autoinflammatory Diseases’ Working Group, in collaboration with PRINTO, set up a a web-based international registry for Autoinflammatory diseases.
    Learn More
  • PharmaChild
    PRINTO and PRES are conducting a pharmacovigilance project which aims at observing children with JIA for 3-10 years undergoing treatment with MTX or biologic agents in order to collect moderate, severe or serious adverse events occurred.
    Learn More
  • EPOCA
    PRINTO is cross-culturally adapting and validating a questionnaire which aims to enable a multidimensional assessment of the disease status and quality of life of children with JIA: the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
    Learn More

CERTIFICATIONS

This website uses cookies. By continuing to browse the website you are agreeing to our use of cookies. Learn more   Accept cookies
Website Security Test